Executive Summary
The petitioner, Director of 'Kerala Kathakali Centre', challenged a notice prohibiting the use of his organization's name for trade purposes under Section 3 of the Emblems and Names (Prevention of Improper Use) Act, 1950. The High Court dismissed the writ petition, holding that the name suggested patronage of the State Government. The subsequent Writ Appeal was also dismissed.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Kerala High Court. Understanding the court's reasoning in K.P.Vijayakumaran @ Kalmandalam vs State Of Kerala is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Gautam BhatiavsVinayak Enterprises
Gautam Bhatia filed an application seeking permission to amend the claims of his Indian Patent No.410993, which relates to a method for preparing an adhesive. The plaintiff sought to narrow the scope of the process and product claims by defining the ratio of modified starch to various powders within a specific range (1:1 to 1:5). Despite the defendant opposing the amendment, the court allowed it, finding that the proposed changes were clarificatory, narrowing the scope, and supported by the original complete specification.
Novartis Ag.vsCipla Ltd.
Cipla Ltd. opposed Novartis AG's patent application for a new crystal form of imatinib mesylate. The IPAB found that the subject matter was merely a new form of a known substance without significant enhancement in efficacy, thus failing Section 3(d). Furthermore, the court disqualified the application due to improper claiming of Swiss priority.
Gunjan Sinha @ Kanishk SinhavsThe Union Of India And Another
The petitioner filed a writ petition challenging the validity (vires) of Section 53 of the Patents Act, 1970. The petitioner argues that this section is contrary to Section 11A(7) because it restricts patent subsistence based on the date of application rather than the date of publication. The court addressed preliminary objections regarding jurisdiction and res judicata before adjourning the matter for arguments on merits.
Bristol Myers Squibb CompanyvsDeputy Controller of Patents, Patent Office
Bristol Myers Squibb appealed the rejection of its patent application for a new hemisulphate salt of Compound (I), which was based on Section 3(d) of the Patents Act, 1970. The appellant argued that the compound demonstrated enhanced bioavailability and therapeutic efficacy compared to the free base form. The High Court set aside the rejection order and remanded the matter for reconsideration by a different officer.
Thyssenkrupp Rothe Erde Germany GmbhvsIMO Holding Gmbh
The petitioner filed a Transfer Original Petition (Patents) challenging the validity of Patent IN254458, arguing that it lacked novelty and did not comply with relevant provisions of the Patents Act. However, the counsel for the petitioner subsequently informed the court that they had reached a settlement with the contesting respondent.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.